The Valley Desk

Clinical trial reportGynecologic oncologyPublished

Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name GSK, Jefferson Health, Sidney Kimmel Medical College, Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Gynecologic oncology
Published
Subject terms
Humans; Endometrial Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Carboplatin; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Adult; Aged; Middle Aged; Female; Antibodies, Monoclonal, Humanized
PubMed ID
39531903
Added to directory
Source checked

Report a correction or request removal